The parents of a two-year-old girl diagnosed with childhood dementia are urgently seeking more funding for the rare disease to save their daughter. Gus and Emily Forrester received the heartbreaking news five months ago that their daughter Leni has Sanfilippo disease, a rare genetic neurodegenerative disorder with no cure, limiting life expectancy to the teenage years or early 20s.
As Leni, described as a joyful child, continues to reach developmental milestones, her family is acutely aware that she may gradually lose her physical and cognitive abilities in the years ahead. Emily and Gus, speaking to ITV News, expressed the devastating impact of the situation, calling it “every parent’s worst nightmare.”
Sanfilippo disease causes a deficiency in the enzyme that breaks down harmful molecules in the body, leading to progressive brain damage as the individual ages. While Leni currently appears healthy, the irreversible decline typically begins around age three, eventually affecting the ability to walk, talk, eat, and necessitating constant care.
Despite the lack of a cure or approved treatment in the UK, a new clinical trial for the disease will commence in the US later this year. Leni’s parents are urging the UK government to support the study for broader access to potential treatments. Professor Brian Bigger has developed a therapy that could benefit Sanfilippo patients, emphasizing the crucial need for government funding to initiate clinical trials.
Time is of the essence, as Leni’s parents stress the urgency of early intervention to prevent irreversible damage. They are advocating for increased newborn screening to identify rare genetic conditions and pushing for more research funding. The Forrester family’s fight for Leni’s future is characterized by frustration over limited access to promising treatments and the race against time to prevent further deterioration.
The Department of Health and Social Care acknowledges the challenges faced by those with rare conditions like Sanfilippo syndrome, emphasizing efforts to expedite diagnosis, enhance specialist care, and advance dementia research. The emotional journey of Leni’s family underscores the critical need for support and resources to combat childhood dementia and rare genetic disorders effectively.
